Trial record 1 of 1 for:    NCT01387555
Previous Study | Return to List | Next Study

A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib (TRAVERSE)

This study has been completed.
Information provided by (Responsible Party):
Jennerex Biotherapeutics Identifier:
First received: June 27, 2011
Last updated: March 10, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)